Qualigen Therapeutics Presents Three Posters of QN-302 at American Association of Cancer Research Conference
12 avr. 2022 10h15 HE
|
Qualigen Therapeutics, Inc.
Data Highlights In Vivo Research and the Potential Mechanism of Action in Pancreatic and Prostate Cancers CARLSBAD, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc....